Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Obesity 3Urologic Neoplasms 1Stomach Neoplasms 1Smoking 1Sarcopenia 1Risk Reduction Behavior 1Rectal Neoplasms 1Postoperative Complications 1Patient Preference 1Overweight 1Motor Activity 1Malnutrition 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Alcohol Drinking 1

Interventions

Fluorouracil 497Bevacizumab 476Oxaliplatin 449Leucovorin 440Irinotecan 408Cetuximab 317Capecitabine 317pembrolizumab 142Folfox protocol 129Panitumumab 117regorafenib 105Colonoscopy 88Nivolumab 81IFL protocol 81Drug Therapy 77trifluridine tipiracil drug combination 73Radiotherapy 66HMPL-013 65Blood Specimen Collection 52Gemcitabine 49Specimen Handling 46Neoadjuvant Therapy 45Standard of Care 44Magnetic Resonance Spectroscopy 43Biopsy 43Chemotherapy, Adjuvant 41Trifluridine 40atezolizumab 38Surveys and Questionnaires 38Cyclophosphamide 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Adiposity × Clear all
NCT06606912 2024-09-23

Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Gastric Cancer Patients

First Affiliated Hospital of Chongqing Medical University

Active not recruiting
4,000 enrolled
GastrointestinalOther

Gastrointestinal Neoplasms, Obesity, Stomach Neoplasms, Colorectal Neoplasms, Overweight, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡